Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Integrated ChIP-seq and Transcriptomic Profiling of Histone Modifications Across Breast Cancer Progression in MCF10A-Derived Cell Lines [ChIP-Seq]

ABSTRACT: Integrated ChIP-seq and Transcriptomic Profiling of Histone Modifications Across Breast Cancer Progression in MCF10A-Derived Cell Lines [ChIP-Seq]

PROVIDER: PRJNA1132958 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Integrated ChIP-seq and Transcriptomic Profiling of Histone Modifications Across Breast Cancer Progression in MCF10A-Derived Cell Lines [ChIP-Seq]

Project description:Cancer arises from complex epigenetic mechanisms that drive tumorigenesis. Gene regulatory elements play a pivotal role in reprogramming gene expression patterns, facilitating tumor initiation, progression, and metastasis. However, a comprehensive characterization of epigenetic alterations across cancer development remains incomplete, particularly for the spectrum of post-translational histone modifications in the evolution of breast tumors. In this study, we explored the dynamic landscape of epigenetic changes using a breast cancer progression model based on the MCF10A cell line. We integrated ChIP-seq and transcriptomic profiling to investigate the epigenetic heterogeneity across four MCF10A-derived cancer cell lines: normal (MCF10A), HRAS G12V transformed, ductal carcinoma in situ (DCIS), and metastatic (CA1a). Our analysis revealed significant changes in chromatin patterns at regulatory elements, including stage-specific variability in H3K27me3 and H3K9me3-marked heterochromatin domains. These profiles underly the epigenomic changes in each of these cell states to provide insights into human breast cancer progression.

2025-07-05 | GSE271703 | GEO

ChIP-seq for histone modifications during MCF10A-ER-Src cell transformation

Project description:We performed ChIP-seq for histone modifications to map chromatin status and dynamics during MCF10A-ER-Src cell transformation.

2017-07-03 | GSE100257 | GEO

SUMO2 ChIP-seq in MCF10A cells

Project description:SUMO2 ChIP-seq in MCF10A cells

| PRJEB31667 | ENA

ChIP-seq for H3K4me3, H3K27me3, H3K79me2 in MCF10A cells

Project description:We performed ChIP-Seq against histones H3K4me3, H3K27me3, and H3K79me2 in MCF10A cells to identify transcription factors with bivalent and pseudo-bivalent epigenetic modifications.

2018-02-01 | GSE109721 | GEO

H3K27ac ChIP-seq of MCF10A progression series

Project description:H3K27ac ChIP-seq of MCF10A progression series

| PRJNA752355 | ENA

ChIP-AP - An Integrated ChIP-Seq Analysis Pipeline

Project description:ChIP-AP - An Integrated ChIP-Seq Analysis Pipeline

| PRJNA723011 | ENA

ChIP-seq for H3K4me3, H3K27me3, H3K79me2 in MCF10A cells

Project description:ChIP-seq for H3K4me3, H3K27me3, H3K79me2 in MCF10A cells

| PRJNA431792 | ENA

Identification of ChIP-seq and RIME grade antibodies for Estrogen Receptor alpha

Project description:Estrogen Receptor alpha (ERα) is a key driver of most breast cancers, and it is the target of endocrine therapies used in the clinic to treat women with ERα positive (ER+) breast cancer. The two methods ChIP-seq (chromatin immunoprecipitation coupled with deep sequencing) and RIME (Rapid Immunoprecipitation of Endogenous Proteins) have greatly improved our understanding of ERα function during breast cancer progression and in response to anti-estrogens. A critical component of both ChIP-seq and RIME protocols is the antibody that is used to pull down the bait protein. To date, most of the ChIP-seq and RIME experiments for the study of ERα have been performed using the sc-543 antibody from Santa Cruz Biotechnology. However, this antibody has been discontinued, thereby severely impacting the study of ERα in normal physiology as well as diseases such as breast cancer and ovarian cancer. Here, we compare the sc-543 antibody with other commercially available antibodies, and we show that 06-935 (EMD Millipore) and ab3575 (Abcam) antibodies can successfully replace the sc-543 antibody for ChIP-seq and RIME experiments.

2019-03-21 | PXD012930 | Pride

Chromatin profiles of chromosomally integrated human herpesvirus-6A [ChIP-seq]

Project description:We report the regulatory chromatin of the chromosomally integrated HHV6 genome. Using ChIP-seq analysis, we find that the integrated virus is transcriptionally inactive and is enriched with distinct patterns of posttranslational histone modifications and TRF1/2.

2019-08-15 | GSE121985 | GEO

ChIP seq of CTCF and p53 in MCF10A before and after H-RAS transformation [ChIP-seq]

Project description:ChIP seq of CTCF and p53 in MCF10A before and after H-RAS transformation [ChIP-seq]

| PRJNA589053 | ENA